Inhibition of myocardial fatty acid oxidation for the treatment of heart failure

被引：0
|
作者：
Stanley, WC [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2004年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：352 / 353
页数：2
相关论文
共 50 条
  • [1] Partial fatty acid oxidation inhibition: A novel approach for the treatment of heart failure
    Sabbah, HN
    Stanley, WC
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A154 - A154
  • [2] Inhibition of fatty acid oxidation as a pharmacological approach to treating heart failure
    Stanley, William C.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 35 - 35
  • [3] Modulating fatty acid oxidation in heart failure
    Lionetti, Vincenzo
    Stanley, William C.
    Recchia, Fabio A.
    CARDIOVASCULAR RESEARCH, 2011, 90 (02) : 202 - 209
  • [4] Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation
    Chandler, MP
    Kerner, J
    Huang, H
    Vazquez, E
    Reszko, A
    Martini, WZ
    Hoppel, CL
    Imai, M
    Rastogi, S
    Sabbah, HN
    Stanley, WC
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (04): : H1538 - H1543
  • [5] New directions in the treatment of heart failure: Targeting free fatty acid oxidation
    Fragasso G.
    Spoladore R.
    Bassanelli G.
    Cuko A.
    Montano C.
    Salerno A.
    Margonato A.
    Current Heart Failure Reports, 2007, 4 (4) : 236 - 242
  • [6] Deranged Myocardial Fatty Acid Metabolism in Heart Failure
    Yamamoto, Tsunehisa
    Sano, Motoaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [7] Myocardial fatty acid metabolism and cardiac performance in heart failure
    Tuunanen H.
    Ukkonen H.
    Knuuti J.
    Current Cardiology Reports, 2008, 10 (2) : 142 - 148
  • [8] Free fatty acid kinetics and oxidation in congestive heart failure
    Lommi, J
    Kupari, M
    Yki-Järvinen, H
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (01): : 45 - 50
  • [9] Fatty acid oxidation inhibition with PPARα activation (FOXIB/PPARα) for normalizing gene expression in heart failure?
    Rupp, H
    Rupp, TP
    Maisch, B
    CARDIOVASCULAR RESEARCH, 2005, 66 (03) : 423 - 426
  • [10] Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?
    Issa, Jean
    Lodewyckx, Pierre
    Blasco, Helene
    Benz-de-Bretagne, Isabelle
    Labarthe, Francois
    Lefort, Bruno
    ESC HEART FAILURE, 2023, : 3114 - 3122
12345